Expert Interview
Discussing the IPSC and NK cell infusion landscape in the oncology space with a focus on technologies in development by Editas and Fate Therapeutics
Ticker(s): FATE, EDITInstituion: University of Minnesota
- Professor of Immunology at the University of Minnesota with appointments in the Masonic Cancer Center, Center for Immunology, and the Stem Cell Institute.
- Research program is focused on leukocyte biology with a focus on natural killer cells and their engineering to enhance cancer cell recognition and killing.
- Lab studies various aspects of leukocyte biology and innate immunity with a focus on neutrophils and natural killer (NK) cells, which play a key role in killing virus-infected cells and cancer cells.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
